John A. Stalfort III, Director at Acumen Pharmaceuticals, Inc. (ABOS), bought 165,180 shares at $16.00 ($560K) on 2021-07-06, disclosed to the SEC on 2021-07-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 130,180 | $0 | 0.0% |
| 2 | $16.00 | 35,000 | $560K | 100.0% |
| Total | $3.39 avg | 165,180 | $560K | 100% |
| Filing → |